Choose a channel
Check out the different Progress in Mind content channels.
Progress in Mind
Addressing adherence issues in depression management
Despite the fact that antidepressant therapy is essential for positive patient outcomes, many patients remain non-adherent to their prescribed treatment plan.1
Less than a third of patients with depression receive and take their medication appropriately1
In fact, almost half of outpatients who are prescribed an antidepressant discontinue treatment within the first month,1,2 with almost 70% discontinuing within 3 months, depending on the medication prescribed.1
What’s causing this?
The reasons for this potential non-adherence differ between patients. However, a number of factors could be contributing to a patient’s non-compliance with therapy, including:1
How can you help?
Some healthcare professionals recommend addressing patients’ potential adherence difficulties through a collaborative approach to their care. Working together can help to reinforce a positive physician–patient relationship, and provide insights into the patient’s own priorities for treatment outcomes. This, in turn, can provide motivation for the patient to comply with treatment, in pursuit of change that is both helpful and important to them.3
Additionally, the provision of education regarding the importance of compliance in antidepressant treatment can improve patient adherence to therapy. One randomised, controlled, prospective study found that the administration of a monthly, mail-based education programme had a positive influence on patients’ compliance.4
Even the introduction into appointments of simple and specific educational messages about antidepressant treatment and adherence have been shown to enhance compliance with therapy, at least in primary care settings.5 Above all, it is essential to emphasise the importance of continuing with treatment to patients with depression, even after improvement or cessation of symptoms.